CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma

Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

(2019) Cameron Trodello et al.   DERMATOLOGIC SURGERY

Primary analysis of phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).

(2019) Michael Robert Migden et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.

(2019) Alexander David Guminski et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment patterns and outcomes among patients with advanced cutaneous squamous cell carcinoma (CSCC) in a US community oncology setting.

(2019) C. Lance Cowey et al.   JOURNAL OF CLINICAL ONCOLOGY

Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns—Results of a non-interventional study of the DeCOG

(2018) Uwe Hillen et al.   EUROPEAN JOURNAL OF CANCER

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

(2018) Michael R. Migden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

(2018) Lawrence Blonde et al.   ADVANCES IN THERAPY

Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial

(2017) William N. William et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice

(2017) Elena Burova et al.   MOLECULAR CANCER THERAPEUTICS

Consensus for Nonmelanoma Skin Cancer Treatment, Part II

(2015) Arielle N. B. Kauvar et al.   DERMATOLOGIC SURGERY

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

(2015) Alexander Stratigos et al.   EUROPEAN JOURNAL OF CANCER

Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012

(2015) Howard W. Rogers et al.   JAMA Dermatology

Patient reported outcome measures could help transform healthcare

(2013) N. Black   BMJ-British Medical Journal

A systematic review of worldwide incidence of nonmelanoma skin cancer

(2012) A. Lomas et al.   BRITISH JOURNAL OF DERMATOLOGY

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

(2011) Eve Maubec et al.   JOURNAL OF CLINICAL ONCOLOGY